オプション
～
検索条件をクリア

書籍詳細

未契約
書籍名 改訂新版 補助循環マニュアル ―最新情報で学ぶ基本と実践
出版社 メディカ出版
発行日 2023-11-01
著者
  • 松宮護郎(医学監修)
  • 東條圭一(編集)
ISBN 9784840482202
ページ数 291
版刷巻号 電子書籍版
分野
閲覧制限 未契約

急速に普及が進むImpella、そしてECMOの台頭という近年の大きな変化を汲んでの大幅改訂。前版で支持された第一線の医師と臨床工学技士による共同執筆、図・写真を多用して視覚的理解を重視、各社装置・デバイスの特徴を現場目線で解説、という基本コンセプトは踏襲し、補助循環の初学者が一から学べて、チーム力の質向上に役立つ1冊となっている。

目次

  • 表紙
  • 本書について
  • 序文
    iii
  • Contents
    v
  • 執筆者一覧
    viii
  • [ 第1章 ] 総論
    P.1
    • 1 補助循環の適応病態
    • 2 補助循環の種類と使い分け
  • [ 第2章 ] IABP
    P.15
    • 1 原理、適応と禁忌
    • 2 各社IABP装置およびバルーンの特徴
    • 3 準備と装着の実際
    • 4 合併症とその対策、離脱の実際
    • 5 装置面の事故防止・安全対策、保守・点検
  • [ 第3章 ] Impella
    P.61
    • 1 原理・病態生理
    • 2 Impella装置とカテーテルの特徴
    • 3 適応と禁忌
    • 4 準備と装着の実際
    • 5 合併症とその対策
    • 6 離脱の実際
    • 7 装置面の事故防止・安全対策、保守・点検
  • [ 第4章 ] V - A ECMO
    P.111
    • 1 原理・病態生理
    • 2 各社ECMO装置・遠心ポンプ、人工肺の特徴
    • 3 適応と禁忌
    • 4 準備と装着の実際
    • 5 補助循環中の全身管理 ( 合併症とその対策 )
    • 6 装置面の事故防止・安全対策
    • 7 離脱の実際 ( 離脱、ECPELLA・VADへの移行 )
    • 8 長期管理の実際
    • 9 ECPR
  • [ 第5章 ] V - V ECMO・ハイブリッドECMO
    P.175
    • 1 V - V ECMOの定義と原理・病態生理
    • 2 呼吸ECMOの適応と禁忌
    • 3 V - V ECMOの管理と離脱の実際
    • 4 ハイブリッドECMOの分類と適応
    • 5 ハイブリッドECMOの管理と離脱の実際
    • 6 準備と装着の実際
    • 7 長期管理の実際
  • [ 第6章 ] 植込型補助人工心臓 ( 植込型VAD )
    P.223
    • 1 補助人工心臓 ( VAD ) の分類と原理
    • 2 各社植込型VAD装置の特徴
    • 3 植込型補助人工心臓の適応
    • 4 準備と装着の実際
    • 5 術後管理の要点 ( 合併症とその対策 )
    • 6 長期管理の実際
  • 索引
    P.271
  • 奥付

参考文献

[ 第1章 ] 総論

P.8 掲載の参考文献

  • 1) Stevenson LW, et al. INTERMACS profiles of advanced heart failure:the current picture. J Heart Lung Transplant. 28(6), 2009, 535-41.
    pubmed
  • 2) 日本循環器学会/日本心不全学会合同ガイドライン. 2021年 JCS/JHFS ガイドラインフォーカスアップデート版 急性・慢性心不全診療. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Tsutsui.pdf
  • 3) 補助人工心臓関連学会協議会 J-MACS Sta https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Tsutsui.pdf
  • 3) tistical Report(2010年6月-2022年12月)https://j-vad.jp/document/statistical_report_20230215.pdf
  • 4) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会合同ガイドライン. 2021年改訂版. 重症心不全に対する植込型補助人工心臓治療ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Ono_Yamaguchi.pdf
  • 5) Estep JD, et al. ROADMAP Study Investigators. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients:results from the ROADMAP Study. J Am Coll Cardiol. 66(16), 2015, 1747-61.
  • 6) MOller JE, et al. Step by step daily management of short-term mechanical circulatory support for cardiogenic shock in adults in the intensive cardiac care unit:a clinical consensus statement of the Association for Acute CardioVascular Care of the European Society of Cardiology SC, the European Society of Intensive Care Medicine, the European branch of the Extracorporeal Life Support Organization, and the European Association for Cardio-Thoracic Surgery. Eur Heart J Acute Cardiovasc Care. 12(7), 2023, 475-85.
  • 7) 補助人工心臓治療関連学会協議会. 循環補助使用中のNYHA クラスと profile 分類のコンセンサス(2022.4.18確定). https://j-vad.jp/document/循環補助使用中のNYHAクラスとprofile分類のコンセンサス. pdf?ver=20220419A

P.12 掲載の参考文献

  • 1) Thiele H, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 367(14), 2012, 1287-96.
    pubmed
  • 2) Tanaka A, et al. The subclavian intraaortic balloon pump:A compelling bridge device for advanced heart failure. Ann thorac Surg. 100(6), 2015, 2151-7.
  • 3) Schrage B, et al. Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation:results from an international, multicenter cohort study. Circulation. 142(22), 2020, 2095-106.
    pubmed
  • 4) Napp LC, et al. Cannulation strategies for percutaneous extracorporeal membrane oxygenation in adults. Clin Res Cardiol. 105(4), 2016, 283-96.
    pubmed
  • 5) Basir MB, et al. Improved outcomes associated with the use of shock protocols:Updates from the national cardiogenic shock initiative. Catheter Cardiovasc Interv. 93(7), 2019, 1173-83.
    pubmed
  • 6) Ikeda Y, et al. Short-term outcomes of Impella support in Japanese patients with cardiogenic shock due to acute myocardial infarction-Japanese Registry for Percutaneous Ventricular Assist Device(J-PVAD). Circ J. 87(5), 2013, 588-97.
  • 7) Iyengar A, et al. Comparison of Intraaortic Balloon Pump and Impella 5.5 as Heart Transplant Bridging Strategies. Ann Thorac Surg. 2023:S0003-4975(23)00685-9. doi:10.1016.
  • 8) 補助人工心臓関連学会協議会J-MACS StatisticalReport(2010年6月-2022年12月)https://j-vad.jp/document/statistical_report_20230215.pdf

[ 第2章 ] IABP

P.21 掲載の参考文献

  • 1) Swartz MT, et al. Effects of Intraaortic Balloon Position on Renal Artery Blood Flow. Ann Thorac Surg. 53, 1992, 604-10.
  • 2) 吉岡幸男ほか. 日本人の体格に適した IABP バルーンサイズの検討. 胸部外科. 40(9), 1987, 736-42.
  • 3) アロウジャパン株式会社. 大動脈内バルーンパンピング装置 Auto CAT2WAVE. 体外循環技術. 34(1), 2007, 66-9.
    Medical*Online

P.33 掲載の参考文献

  • 1) Manshadi SD, et al. Vascular Complications With Intra-aortic Balloon Pump (IABP):Experience From a Large Canadian Metropolitan Centre. CJC Open. 4(11), 2022, 989-93.
  • 2) 添田信之ほか. IABP(大動脈)の長さと径の検討. 循環器科. 41, 1997, 331-2.
  • 3) Igari T. The length of the aorta from the subclavian artery to the renal artery based on computed tomographic measurements in Japanese adults. J Artif Organs. 9, 2006, 267-70.
  • 4) 武田章数ほか. IAB カテーテル留置位置の変化に関する検討. 体外循環技術. 33(2), 2006, 147-9.
    Medical*Online
  • 5) Sakamoto T, et al. Effects of timing on ventriculoarterial coupling and mechanical efficiency during intraaortic balloon pumping. ASAIO J. 41, 1995, M580-3.
    pubmed
  • 6) Schreuder JJ, et al. Beat-to-Beat Effects of Intraaortic Balloon Pump Timing on Left Ventricular Performance in Patients With Low Ejection Fraction. Ann Thorac Surg. 79, 2005, 872-80.
    pubmed
  • 7) Sakamoto T, et al. New algorithm of intra-aortic balloon pumping in patients with atrial fibrillation. ASAIO J. 41, 1995, 79-83.
    pubmed

P.44 掲載の参考文献

  • 1) 澤芳樹. "患者の管理, 合併症". プラクティカル補助循環ガイド. メディカ出版, 2008, 78-83.
  • 3) 許俊鋭ほか編. "IABP バルーンと駆動装置". 補助循環マスターポイント102. メジカルビュー社, 2009, 48-50.
  • 4) 澤芳樹. "IABP 装着, 離脱". プラクティカル補助循環ガイド. メディカ出版, 2008, 84-9.
  • 5) 阿部稔雄ほか編. 最新人工心肺. 第二版. 名古屋大学出版会, 2003, 209-32.
  • 6) 井野隆史ほか編. 最新体外循環. 第二版. 金原出版, 2003, 226-70.
  • 7) 荒木康幸. IABPのしくみと取り扱い方法. HEARTNURSING. 21(7), 2008, 31-9.
  • 8) 百瀬直樹. 呼吸器&循環器ケア 6・7月号. 日総研出版, 2009, 55-68.
  • 9) 荒井裕国. 大動脈内バルーンパンピング法. 体外循環と補助循環 2009 第25回教育セミナー. 2009, 15-26.

P.49 掲載の参考文献

  • 1) Swartz MT, et al. Effects of Intraaortic Balloon Position on Renal Artery Blood Flow. Ann Thorac Surg. 53, 1992, 604-10.

P.59 掲載の参考文献

  • 1) 日本集中治療医学会. 臨床工学技士集中治療テキスト. 日本集中治療医学会, 2019, 288-95.
  • 2) 山口敦史ほか. 人工心肺ハンドブック. 改訂3版. 中外医学社, 2020, 183-90.
  • 3) 羽田貴宏. ME機器アラームのメカニズム:IABP装置のアラーム. CIin Eng. 19(1), 2008, 40-5.
  • 4) 加納隆ほか. そのトラブル, どう対処する? 補助循環デバイス編 IABPのトラブル. CIin Eng. 33(5), 2022, 479-91.
  • 5) 荒木康幸編著. 動画で解説!IABP・PCPS・CHDF・ペースメーカ アラーム&トラブル対応. 日総研, 2015, 29-63.
  • 6) 土井貴仁. "IABPとは". 新版プラクティカル補助循環ガイド:研修医・看護師・臨床工学技士のための. 澤芳樹総監修. メディカ出版, 2016, 70-96.
  • 7) 山名比呂美編著. はじめての補助循環-カラービジュアルで見てわかる! ナースのための IABP・PCPS 入門書. 向原伸彦監修. メディカ出版, 2013, 27-69.
  • 8) 泉工医科工業株式会社. コラート BP3 取扱説明書・パンフレット.
  • 9) ゲティンゲグループ・ジャパン株式会社. CARDIOSAVE HYBRID 取扱説明書・パンフレット.
  • 10) 2021年厚生労働省発. 医療機器に係る安全管理のための体制確保に係る運用上の留意点について.
  • 11) 日本臨床工学技士会. 医療機器管理に関する報告書・指針 医療機器安全管理指針第1版. http://ja-ces.or.jp/wordpress/ce/wp-content/uploads/2013/03/089a9b030c6a90b3045f15891d2d9fce.pdf(2023年7月18日閲覧)

[ 第3章 ] Impella

P.66 掲載の参考文献

  • 1) O'Neill WW, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock:results from the USpella Registry. J Interv Cardiol. 27(1), 2014, 1-11.
    pubmed
  • 2) Casassus F, et al. The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction. J Interv Cardiol. 28(1), 2015, 41-50.
    pubmed
  • 3) Burkhoff D, et al. Hemodynamics of Mechanical Circulatory Support. J Am Coll Cardiol. 66(23), 2015, 2663-74.
    pubmed
  • 4) Remmelink M, et al. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics. Catheter Cardiovasc Interv. 70(4), 2007, 532-7.
    pubmed
  • 5) Combes A, et al. Temporary circulatory support for cardiogenic shock. Lancet. 396(10245), 2020, 199-212.
    pubmed
  • 6) Lemaire A, et al. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock. Ann Thorac Surg. 97(1), 2014, 133-8.
    pubmed
  • 7) Seyfarth M, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 52(19), 2008, 1584-8.
  • 8) Ouweneel DM, et al. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol. 69(3), 2017, 278-87.
    pubmed
  • 9) Lusebrink E, et al. Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology. Circulation. 145(16), 2022, 1254-84.
    pubmed
  • 10) Meani P, et al. ECPella:Concept, Physiology and Clinical Applications. J Cardiothorac Vasc Anesth. 36(2), 2022, 557-66.
    pubmed
  • 11) Schrage B, et al. Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation:Results From an International, Multicenter Cohort Study. Circulation. 142(22), 2020, 2095-106.
    pubmed

P.74 掲載の参考文献

  • 1) 山口敦司ほか. 人工心肺ハンドブック. 改訂3版. 中外医学社, 2020, 70-2.
  • 2) 山口敦司ほか. 人工心肺ハンドブック. 改訂3版. 中外医学社, 2020, 65-6.
  • 3) 松下裕貴ほか. "Impella の構造と仕組み:機械的補助を活用するための血行動態基礎知識". 補助循環用ポンプカテーテルマスターガイド:Impella A to Z. 日経メディカル開発, 2023, 8-12.
  • 4) 吉田幸太郎. IMPELLAのトラブル. Clinical Engineering. 33(5), 2022, 468-78

P.79 掲載の参考文献

  • 1) Thiele H, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 367(14), 2012, 1287-96.
    pubmed
  • 2) Ouweneel DM, et al. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol. 69(3), 2017, 278-87.
    pubmed
  • 3) Scherer C, et al. Long-Term Clinical Outcome of Cardiogenic Shock Patients Undergoing Impella CP Treatment vs. Standard of Care. J Clin Med. 9(12), 2020, 3803.
    pubmed
  • 4) Karatolios K, et al. Impella support compared to medical treatment for post-cardiac arrest shock after out of hospital cardiac arrest. Resuscitation. 126, 2018, 104-10.
    pubmed
  • 5) Dhruva SS, et al. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. JAMA. 323(8), 2020, 734-45.
    pubmed
  • 6) Amin AP, et al. The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support. Circulation. 141(4), 2020, 273-84.
    pubmed
  • 7) Seyfarth M, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 52(19), 2008, 1584-8.
  • 8) Garan AR, et al. Prospective Comparison of a Percutaneous Ventricular Assist Device and Venoarterial Extracorporeal Membrane Oxygenation for Patients With Cardiogenic Shock Following Acute Myocardial Infarction. J Am Heart Assoc. 8(9), 2019, e012171.
    pubmed
  • 9) Karami M, et al. Mechanical circulatory support in cardiogenic shock from acute myocardial infarction:Impella CP/5.0 versus ECMO. Eur Heart J Acute Cardiovasc Care. 9(2), 2020, 164-72.
  • 10) Schiller P, et al. Survival after refractory cardiogenic shock is comparable in patients with Impella and veno-arterial extracorporeal membrane oxygenation when adjusted for SAVE score. Eur Heart J Acute Cardiovasc Care. 8(4), 2019, 329-37.
    pubmed
  • 11) Lemor A, et al. Impella Versus Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock. Cardiovasc Revasc Med. 21(12), 2020, 1465-71.
    pubmed
  • 12) Udesen NJ, et al. Rationale and design of DanGer shock:Danish-German cardiogenic shock trial. Am Heart J. 214, 2019, 60-8.
    pubmed
  • 13) Boyle AJ, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant. 30(4), 2011, 402-7.
    pubmed
  • 14) Arabia FA, et al. Interagency registry for mechanically assisted circulatory support report on the total artificial heart. J Heart Lung Transplant. 37(11), 2018, 1304-12.
    pubmed
  • 15) Arora S, et al. Temporary Mechanical Circulatory Support as a Bridge to Heart Transplant or Durable Left Ventricular Assist Device. Interv Cardiol Clin. 10(2), 2021, 235-49.
  • 16) Lima B, et al. Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device. Am J Cardiol. 117(10), 2016, 1622-8.
    pubmed
  • 17) Chung JS, et al. A New Paradigm in Mechanical Circulatory Support:100-Patient Experience. Ann Thorac Surg. 109(5), 2020, 1370-7.
    pubmed
  • 18) Morimura H, et al. Delayed surgery after mechanical circulatory support for ventricular septal rupture with cardiogenic shock. Interact Cardiovasc Thorac Surg. 31(6), 2020, 868-73.
    pubmed
  • 19) La Torre MW, et al. Posterior ventricular septal defect in presence of cardiogenic shock:early implantation of the impella recover LP 5.0 as a bridge to surgery. Tex Heart Inst. 38(1), 2011, 42-9.
  • 20) Saito S, et al. Impella support as a bridge to heart surgery in patients with cardiogenic shock. Interact Cardiovasc Thorac Surg. 35(2), 2022, ivac088.
    pubmed
  • 21) Stone GW, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol. 29(7), 1997, 1459-67.
  • 22) Dixon SR, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial):initial U.S. experience. JACC Cardiovas Interv. 2(2), 2009, 91-6.
  • 23) Sjauw KD, et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol. 54(25), 2009, 2430-4.
    pubmed
  • 24) Khalid N, et al. Feasibility and Safety of High-Risk Percutaneous Coronary Intervention Without Mechanical Circulatory Support. Circ Cardiovasc Interv. 14(6), 2021, e009960.
    pubmed
  • 25) Neuzner J, et al. Effectiveness of a percutaneous left ventricular assist device in preventing acute hemodynamic decompensation during catheter ablation of ventricular tachycardia in advanced heart failure patients:A retrospective single-center analysis. J Cardiovasc Electrophysiol. 30(12), 2019, 2864-8.
    pubmed
  • 26) Miller MA, et al. Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist device. J Am Coll Cardiol. 58(13), 2011, 1363-71.
    pubmed
  • 27) Miller MA, et al. Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1). Circ Arrhythm Electrophysiol. 6(1), 2013, 151-9.
    pubmed
  • 28) Muser D, et al. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related ventricular tachycardia:A propensity-score matched analysis. Heart Rhythm. 15(10), 2018, 1500-6.
    pubmed
  • 29) Kusa S, et al. Outcomes of Ventricular Tachycardia Ablation Using Percutaneous Left Ventricular Assist Devices. Circ Arrhythm Electrophysiol. 10(6), 2017, e004717.
    pubmed
  • 30) Aryana A, et al. Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support:An analysis of the Medicare database. J Cardiovasc Electrophysiol. 28(11), 2017, 1295-302.
    pubmed
  • 31) Orvin K, et al. Percutaneous mechanical circulatory support from the collaborative multicenter Mechanical Unusual Support in TAVI (MUST) Registry. Cather Cardiovasc Interv. 98(6), 2021, E862-e9.
  • 32) Hiraoka A, et al. A case report of unexpected right-to-left shunt under mechanical support for post-infarction ventricular septal defect:evaluation with haemodynamic simulator. Eur Heart J Case Rep. 5(8), 2021, ytab209.
    pubmed

P.87 掲載の参考文献

  • 1) 補助人工心臓治療関連学会協議会インペラ部会. インペラ部会補助循環用ポンプカテーテルに関するレジストリ事業 J-PVAD年次報告(2020年2月から2021年12月). https://j-pvad.jp/document/【年次報告】補助循環用ポンプカテーテルに関するレジストリ事業_20220831.pdf(2023年7月1日閲覧)
  • 2) 中村牧子. Impella(R)の適応・管理について. Heart View. 24(4), 2020, 348-53.
    Medical*Online
  • 3) 日本循環器学会. フォーカスアップデート版 PCPS/ECMO/循環補助用心内留置型ポンプカテーテルの適応・操作. https://www.j-circ.or.jp/cms/wp-content/uploads/2023/03/JCS2023_nishimura.pdf(2023年7月1日閲覧)
  • 4) 今村輝彦ほか. IMPELLA による循環補助の有用性と限界. 心臓. 52(5), 2020, 478-81.
    Medical*Online
  • 5) 日本アビオメッド株式会社. Impella テキストブック.

P.95 掲載の参考文献

  • 1) Lauten A, et al. Percutaneous Left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock:result of the Impella-EUROSHOCK-registry. Circ Heart Fail. 6(1), 2013, 23-30.
    pubmed
  • 2) Schrage B, et al. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Circulation. 139(10), 2019, 1249-58.
    pubmed
  • 3) O'Neill, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock:results from the USpella Registry. J Interv Cardiol. 27(1), 2014, 1-11.
    pubmed
  • 4) Alushi B, et al. Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock. Open Heart. 6(1), 2019, e000987.
    pubmed
  • 5) Basir MB, et al. Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock. Catheter Cardiovasc Interv. 99(3), 2022, 650-7.
    pubmed
  • 6) Tehrani BN, et al. A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock. JACC Heart Fail. 8(11), 2020, 879-91.
  • 7) Toda K, et al. Three-year experience of catheter-based micro-axial left ventricular assist device, Impella, in Japanese patients:the first interim analysis of Japan registry for percutaneous ventricular device (L-PVAD). J Artif Organs. 26(1), 2023, 17-23.

P.101 掲載の参考文献

  • 1) Schrage B, et al. Unloading of the Left Ventricle During Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock. JACC Heart Fail. 6, 2018, 1035
    pubmed
  • 2) Braunwald G. Myocardial oxygen consumption:the quest for its determinants and some clinical fallout. J Am Coll Cardiology. 34, 1999, 1365-8.

P.109 掲載の参考文献

  • 1) Mir BB, et al. Improved Outcomes Associated with the use of Shock Protocols:Updates from the National Cardiogenic Shock Initiative. Catheter Cardiovasc Interv. 93(7), 2019, 1173-83.
  • 2) 堂前圭太郎. 補助循環用ポンプカテーテルマスターガイド-Impella A to Z. 日経メディカル開発, 2023, 148-52.

[ 第4章 ] V - A ECMO

P.117 掲載の参考文献

  • 1) 日本経皮的心肺補助研究会ホームページ. PCPSの定義. http://www2.convention.co.jp/pcps/(2023年8月27日閲覧)

P.128 掲載の参考文献

  • 1) 窪田將司. 膜型人工肺の膜の種類と特徴について教えてください. 新ME早わかり Q&A 2. 人工心肺・補助循環装置(「新ME早わかり Q&A」編集委員会). 東京, 南江堂, 2017, p.27-37.
  • 2) 一般社団法人日本呼吸療法医学会/日本経皮的心肺補助研究会編. ECMO・PCPSバイブル. 大阪, メディカ出版, 2021, p.38-47.
  • 3) 西村元延(監修), 関口 敦 (編著). 最新にして上々!補助循環マニュアル. 大阪, メディカ出版, 2015, p.133-45.
  • 4) 日本体外循環技術医学会(JaSECT)安全対策委員会. 人工心肺ならびに補助循環に関するインシデント・アクシデントおよび安全に関するアンケート 2021(集計報告). https://jasect.org/4182(2023年7月1日閲覧).

P.134 掲載の参考文献

  • 1) 2023年 JCS/JSCVS/JCC/CVIT ガイドライン フォーカスアップデート版 PCPS/ECMO/循環補助用心内留置型 ポンプカテーテルの適応・操作. https://www.j-circ.or.jp/cms/wp-content/uploads/2023/03/JCS2023_nishimura.pdf(2023年8月27日閲覧)
  • 2) Baran DA, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock:This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv. 94(1), 2019, 29-37.

P.142 掲載の参考文献

  • 1) Extracorporeal Life Support Organization(ELSO)General Guidelines for all ECLS Cases. Version1.4. 2017.
  • 2) Sinert R, et al. Effect of normal saline infusion on the diagnostic utility of base deficit in identifying major injury in trauma patients. Acad Emerg Med. 2006, 13(12), 1269-74.
    pubmed
  • 3) 日本体外循環技術医学会安全対策委員会. 手術室における冷温水槽など水路回路を備える装置の衛生管理. 医療機器安全性情報. No.16, 2015.
  • 4) Jonathan H, et al. Management of aortic insufficiency in the continuous flow left ventricular assist device population. Curr Heart Fail Rep. 2014, 11(1), 103-10.

P.147 掲載の参考文献

  • 1) Toda K, et al. Mechanical circulatory support for adults in Japan:A 10-year perspective. Artif Organs. 47(6), 2023, 914-24.
    pubmed
  • 2) JCS Joint Working Group. Guidelines for Diagnosis and Treatment of Myocarditis (JCS 2009):digest version. Circ J. 75(3), 2011, 734-43.
  • 3) Richardson ASC, et al. Extracorporeal cardiopulmonary resuscitation in adults. Interim guideline consensus statement from the Extracorporeal Life Support Organization. ASAIO J. 67(3), 2021, 221-8.
    pubmed
  • 4) Smith M, et al. Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome:an analysis of the Extracorporeal Life Support Organization (ELSO) registry. Crit Care. 21(1), 2017, 45.
    pubmed
  • 5) Borasino S, et al. Impact of hemolysis on acute kidney injury and mortality in children supported with cardiac extracorporeal membrane oxygenation. J Extra Corpor Technol. 50(4), 2018, 217-24.
    pubmed
  • 6) Aoyama N, et al. National survey of fulminant myocarditis in Japan. Circ J. 66(2), 2002, 133-44.
    pubmed
  • 7) Wong JK, et al. Cerebral and lower limb near-infrared spectroscopy in adults on extracorporeal membrane oxygenation. Artif Organs. 36(8), 2012, 659-67.
    pubmed

P.153 掲載の参考文献

  • 1) 百瀬直樹ほか. "PCPS(経皮的心肺補助装置)/ECMO". 人工心肺ハンドブック. 改訂3版. 東京, 中外医学社, 2020, 169-82.
  • 2) 草浦理. ECMO(PCPS)のトラブル. Clinical Engineering. 33(5), 2022, 457-67.
    Medical*Online
  • 3) 一般社団法人日本体外循環技術医学会. 補助循環の安全管理基準. [https://jasect.org/855 (2023年7月1日閲覧)]
  • 4) The Extracorporeal Life Support Organization (ELSO). ELSO Guidelines for Patient Care, Respiratory & Cardiac Support, ECMO in COVID-19. [https://elso.org/ECMO-resources/elso-ECMO-guidelines.aspx(2023年7月1日閲覧)]

P.158 掲載の参考文献

  • 1) Aoyama N, et al. National survey of fulminant myocarditis in Japan. Circ J. 66(2), 2002, 133-44.
    pubmed
  • 2) Hsu KH, et al. Extracorporeal membranous oxygenation support for acute fulminant myocarditis:analysis of a single center's experience. Eur J Cardiothorac Surg. 40(3), 2011, 682-8.
  • 3) Diddle JW, et al. Extracorporeal membrane oxygenation for the support of adults with acute myocarditis. Critical Care Medicine. 43(5), 2015, 1016-25.
    pubmed
  • 4) Lorusso R, et al. Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients:A 5-year multi-institutional experience. Annals of Thoracic Surgery. 101(3), 2016, 919-26.
    pubmed
  • 5) Sawamura A, et al. Early prediction model for successful bridge to recovery in patients with fulminant myocarditis supported with percutaneous venoarterial extracorporeal membrane oxygenation-Insights from the CHANGE PUMP Study. Circ J. 82(3), 2018; 699-707.
    pubmed
  • 6) Lee YI, et al. Extracorporeal membrane oxygenation for fulminant myocarditis:increase of cardiac enzyme and SOFA Score is associated with high mortality. J Clin Med. 10(7), 2021, 1526.
    pubmed
  • 7) Sakamoto S, et al. Extracorporeal life support for cardiogenic shock or cardiac arrest due to acute coronary syndrome. Ann Thorac Surg. 94(1), 2012, 1-7.
  • 8) Smith M, et al. Duration of veno-arterial extracorporeal life support(VA ECMO)and outcome:an analysis of the Extracorporeal Life Support Organization(ELSO)registry. Crit Care. 21(1), 2017, 45.
    pubmed
  • 9) Lorusso R, et al. ELSO Interim Guidelines for Venoarterial Extracorporeal Membrane Oxygenation in Adult Cardiac Patients. ASAIO J. 67(8), 2021, 827-44.
    pubmed
  • 10) Toda K, et al. Three-year experience of catheter-based micro-axial left ventricular assist device, Impella, in Japanese patients:the first interim analysis of Japan registry for percutaneous ventricular assist device(J-PVAD). J Artif Organs. 26(1), 2023, 17-23.
  • 11) Frank D, et al. Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation:Results From an International, Multicenter Cohort Study. Circulation. 142(22), 2020, 2095-106.
    pubmed

P.167 掲載の参考文献

  • 1) Nishimura M, et al. Importance of luxury flow for critically ill patients receiving a left ventricular assist system. J Artif Organs, 9(4), 2006, 209-13.
    pubmed
  • 2) Brierley J, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock:2007 update from the American College of Critical Care Medicine. Crit Care Med. 37(2), 2009, 666-88.
    pubmed
  • 3) 日本体外循環技術医学会. 安全性情報 No.21 遠心ポンプとドライブユニットとの取り付けに関する留意点について. 2022年10月21日. https://jasect.org/wp/wp-content/uploads/2022/10/20221012anzen.pdf
  • 4) 日本集中治療医学会. 集中治療を要する重症患者の搬送に関わる指針. 2022年3月17日 https://www.jsicm.org/news/upload/220310JSICM_scyjkhks.pdf
  • 5) 医薬品医療機器総合機構. 医療安全情報 No.62 PCPS/ECMO カニューレの抜去事例について. 2022年3月. https://www.pmda.go.jp/files/000245602.pdf
  • 6) 後藤 武, ほか. PCPS 施行中の Mixing Zone に関する数値シミュレーション. 体外循環技術, 39(1), 2012, 47-50.
    Medical*Online
  • 7) 日本循環器学会, ほか. 2023年 JCS/JSCVS/JCC/CVIT ガイドラインフォーカスアップデート版 PCPS/ECMO/循環補助用心内留置型ポンプカテーテルの適応・操作. p20. https://www.j-circ.or.jp/cms/wpcontent/uploads/2023/03/JCS2023_nishimura.pdf
  • 8) ECMOの記録やチェックリストに関する提案. 体外循環技術, 49(2), 2022, 144-52.
    Medical*Online
  • 9) 日本体外循環技術医学会学術委員会. 補助循環の安全管理基準. 2016年10月21日. https://jasect.org/855

P.173 掲載の参考文献

  • 1) Panchal AR, et al. Part 3:Adult Basic and Advanced Life Support:2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 142, 2020, S366-S468.
    pubmed
  • 2) JRC 蘇生ガイドライン 2020 作成編集委員会編. 日本蘇生協議会蘇生ガイドライン 2020. 東京, 医学書院, 2021.
  • 3) Sakamoto T, et al. Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with out-of-hospital cardiac arrest:a prospective observational study. Resuscitation. 85, 2014, 762-8.
    pubmed
  • 4) Higashi A, et al. Shortening of low-flow duration over time was associated with improved outcomes of extracorporeal cardiopulmonary resuscitation in in-hospital cardiac arrest. J Intensive Care. 8, 2020, 39.
    pubmed
  • 5) 日本呼吸療法医学会, 日本経皮的心肺補助研究会編. ECMO・PCPS バイブル. 大阪, メディカ出版, 2021.
  • 6) Abrams D, et al. Extracorporeal cardiopulmonary resuscitation in adults:evidence and implications. Intensive Care Med. 48, 2022, 1-15.
    pubmed
  • 7) 安部隆三ほか. 院内, 院外心停止に対する体外循環を用いた心肺蘇生(ECPR:extracorporeal cardiopulmonary resuscitation). 日本外科学会雑誌. 121, 2020, 572-8.
  • 8) Andersen LW, et al. In-Hospital Cardiac Arrest:A Review. JAMA. 321, 2019, 1200-10.
    pubmed
  • 9) Chen YS, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest:an observational study and propensity analysis. Lancet. 372, 2008, 554-61.
    pubmed
  • 10) Low CJW, et al. Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with cardiac arrest:a comparative meta-analysis and trial sequential analysis. Lancet Respir Med. 2023.
    pubmed
  • 11) Bougouin W, et al. Extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest:a registry study. Eur Heart J. 41, 2019, 1961-71.
  • 12) Tanaka D, et al. The Impact of Vascular Complications on Survival of Patients on Venoarterial Extracorporeal Membrane Oxygenation. Ann Thorac Surg. 101, 2016, 1729-34.
    pubmed
  • 13) Cheng R, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest:a meta-analysis of 1,866 adult patients. Ann Thorac Surg. 97, 2014, 610-6.
    pubmed
  • 14) Wong JK, et al. Cerebral and lower limb near-infrared spectroscopy in adults on extracorporeal membrane oxygenation. Artif Organs. 36, 2012, 659-67.
    pubmed
  • 15) Makdisi G, et al. Use of distal perfusion in peripheral extracorporeal membrane oxygenation. Ann Transl Med. 5, 2017, 103.
    pubmed
  • 16) Kawaguchi R, et al. Reduction of unexpected serious adverse events after introducing medical emergency team. Acute Med Surg. 2, 2015, 244-9.
    pubmed
  • 17) Barbaro RP, et al. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med. 191, 2015, 894-901.
    pubmed
  • 18) Na SJ, et al. The effect of multidisciplinary extracorporeal membrane oxygenation team on clinical outcomes in patients with severe acute respiratory failure. Ann Intensive Care. 8, 2018, 31.
  • 19) Komindr A, et al. Establishing extracorporeal membrane oxygenation team increased number of patients and improved data recording. J Intensive Care. 7, 2019, 11.
    pubmed
  • 20) 安部隆三ほか. 周術期における ECMO ECMO 離脱困難な心原性ショック・重症心不全症例に対する治療戦略. 日本臨床麻酔学会誌. 39, 2019, 142-7.

[ 第5章 ] V - V ECMO・ハイブリッドECMO

P.183 掲載の参考文献

  • 1) Fick A. Uber die Messung des Blutquantums in den Herzventrikeln. Wurzburg:SB-Phys-Med Ges, July 9. 1870.
  • 2) Terragni PP, et al. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med. 175(2), 2007, 160-6.
    pubmed
  • 3) Gattinoni T, et al. Ventilator-related causes of lung injury:the mechanical power. Intensive Care Med. 42(10), 2016, 1567-75.
  • 4) Banavasi H, et al. Management of ARDS-What works and what does not. Am J Med Sci. 362(1), 2021, 13-23.
  • 5) Fan E. Less is More:not(always)simple-the case of extracorporeal devices in critical care. Intensive Care Med. 45(10), 2019, 1451-3.
  • 6) Terragni PP, et al. Extracorporeal CO2 removal. Contrib Nephrol. 165, 2010, 185-96.
    pubmed
  • 7) Anderson HL 3rd, et al. Venovenous extracorporeal life support in neonates using a double lumen catheter. ASAIO Trans. 35(3), 1989, 650-3.
    pubmed

P.188 掲載の参考文献

  • 1) Barbaro RP, et al. Extracorporeal membrane oxygenation support in COVID-19:an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 396(10257), 2020, 1071-8.
    pubmed
  • 2) MacLaren G, et al. Preparing for the Most Critically Ill Patients With COVID-19:The Potential Role of Extracorporeal Membrane Oxygenation. JAMA. 323(13), 2020, 1245.
    pubmed
  • 3) Bartlett RH, et al. Initial ELSO Guidance Document:ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure. ASAIO J. 66(5), 2020, 472-4.
    pubmed
  • 4) Friedrichson B, et al. Insight into ECMO, mortality and ARDS:a nationwide analysis of 45,647 ECMO runs. Crit Care. 25(1), 2021, 38. doi:10.1186/s13054-021-03463-2

P.195 掲載の参考文献

  • 1) 梅井菜央. 体外式膜型人工肺(ECMO). 氏家良人編. 入門 新呼吸療法. 東京, 克誠堂出版, 2023, 130-40.
  • 2) 梅井菜央. ウェットラング, プラズマリークとは?. 竹田晋浩監修. 呼吸 ECMOのすべて Q&A. 東京, 中外医学社, 2021, 71-6.
  • 3) Tonna JE, et al. Management of Adult Patients Supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO):Guideline from the Extracorporeal Life Support Organization(ELSO). ASAIO J. 67(6), 2021, 601-10.
    pubmed
  • 4) Abrams D, et al. Mechanical Ventilation for Acute Respiratory Distress Syndrome during Extracorporeal Life Support. Research and Practice. Am J Respir Crit Care Med. 201(5), 2020, 514-25.
    pubmed
  • 5) Papazian L, et al. Effect of prone positioning on survival in adult patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome:a systematic review and meta-analysis. Intensive Care Med. 48(3), 2022, 270-80.
    pubmed
  • 6) Langer T, et al. "Awake" extracorporeal membrane oxygenation (ECMO):pathophysiology, technical considerations, and clinical pioneering. Crit Care. 20(1), 2016, 150.
    pubmed
  • 7) Cucchi M, et al. Awake extracorporeal life support and physiotherapy in adult patients:A systematic review of the literature. Perfusion. 38(5), 2023, 939-58.
    pubmed
  • 8) Boudreaux JC, et al. Does Tracheostomy Improve Outcomes in Those Receiving Venovenous Extracorporeal Membrane Oxygenation? ASAIO J. 69(6), 2023, e240-e7.
    pubmed
  • 9) Schmidt M, et al. Impact of fluid balance on outcome of adult patients treated with extracorporeal membrane oxygenation. Intensive Care Med. 40(9), 2014, 1256-66.
    pubmed
  • 10) Bridges BC, et al. Extracorporeal Life Support Organization Guidelines for Fluid Overload, Acute Kidney Injury, and Electrolyte Management. ASAIO J. 68(5), 2022, 611-8.
    pubmed
  • 11) McMichael ABV, et al. 2021 ELSO Adult and Pediatric Anticoagulation Guidelines. ASAIO J. 68(3), 2022, 303-10.
    pubmed
  • 12) 梅井菜央. 膜型人工肺における抗凝固. 臨床麻酔. 46(4), 2022, 517-26.
    Medical*Online
  • 13) Rajsic S, et al. Anticoagulation Strategies during Extracorporeal Membrane Oxygenation:A Narrative Review. J Clin Med. 11(17), 2022, 5147.
    pubmed
  • 14) Wells CL, et al. Safety and Feasibility of Early Physical Therapy for Patients on Extracorporeal Membrane Oxygenator:University of Maryland Medical Center Experience. Crit Care Med. 46(1), 2018, 53-9.
    pubmed
  • 15) Ferreira DDC, et al. Safety and potential benefits of physical therapy in adult patients on extracorporeal membrane oxygenation support:a systematic review. Rev Bras Ter Intensiva. 31(2), 2019, 227-39.
    pubmed
  • 16) Shekar K, et al. Protocol-driven daily optimisation of venovenous extracorporeal membrane oxygenation blood flows:an alternate paradigm? J Thorac Dis. 12(11), 2020, 6854-60.
    pubmed
  • 17) Pratt EH, et al. A Daily, Respiratory Therapist Assessment of Readiness to Liberate From Venovenous Extracorporeal Membrane Oxygenation in Patients With Acute Respiratory Distress Syndrome. Crit Care Explor. 3(12), 2021, e0584.
    pubmed
  • 18) Gannon WD, et al. Safety and Feasibility of a Protocolized Daily Assessment of Readiness for Liberation From Venovenous Extracorporeal Membrane Oxygenation. Chest. 160(5), 2021, 1693-703.
    pubmed
  • 19) Broman LM, et al. Weaning from veno-venous extracorporeal membrane oxygenation:how I do it. J Thorac Dis. 10(Suppl 5), 2018, S692-S7.
  • 20) Vasques F, et al. How I wean patients from venovenous extra-corporeal membrane oxygenation. Crit Care. 23(1), 2019, 316.
  • 21) Grant AA, et al. A Weaning Protocol for Venovenous Extracorporeal Membrane Oxygenation With a Review of the Literature. Artif Organs. 42(6), 2018, 605-10.
    pubmed

P.201 掲載の参考文献

  • 1) Shah A, et al. Hybrid and parallel extracorporeal membrane oxygenation circuits. JTCVS Tech. 8, 2021, 77-85.
    pubmed
  • 2) 赤嶺 斉ほか. ECMOの生理学:心肺補助における呼吸循環生理の理解が不可欠. INTENSIVIST. 5, 2013, 274.
  • 3) Tonna JE, et al. Management of Adult Patients Supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO):Guideline from the Extracorporeal Life Support Organization (ELSO). ASAIO J. 67, 2021, 601-10.
    pubmed
  • 4) 補助人工心臓治療関連学会協議会インペラ部会. 実施施設一覧 https://j-pvad.jp/facility/
  • 5) Ushijima T, et al. A therapeutic concept to resolve a possible coronary desaturation under Ecpella support and maximize the potential for myocardial recovery:combination of veno-arteriovenous extracorporeal membrane oxygenation and Impella(VAVEcpella). Perfusion. 36, 2021, 535-7.
    pubmed
  • 6) 日本循環器学会/日本心臓血管外科学会/日本心臓病学会/日本心血管インターベンション治療学会. 2023年JCS/JSCVS/JCC/CVIT ガイドラインフォーカスアップデート版 PCPS/ECMO/循環補助用心内留置型ポンプカテーテルの適応・操作. https://www.j-circ.or.jp/cms/wp-content/uploads/2023/03/JCS2023_nishimura.pdf

P.206 掲載の参考文献

  • 1) Shah A, et al. DJ. Hybrid and parallel extracorporeal membrane oxygenation circuits. JTCVS Tech. 8, 2021, 77-85.
  • 2) 日本循環器学会ほか. 2023年 JCS/JSCVS/JCC/CVIT ガイドラインフォーカスアップデート版 PCPS/ECMO/循環補助用心内留置型ポンプカテーテルの適応・操作. https://www.j-circ.or.jp/cms/wp-content/uploads/2023/03/JCS2023_nishimura.pdf
  • 3) Oki T, et al. Inhaled nitric oxide for ECPELLA management in fulminant myocarditis complicated with severe right ventricular dysfunction:A case report. J Cardiol Cases. 26, 2022, 104-7.
    pubmed
  • 4) Ushijima T, et al. A therapeutic concept to resolve a possible coronary desaturation under Ecpella support and maximize the potential for myocardial recovery:combination of veno-arteriovenous extracorporeal membrane oxygenation and Impella (VAVEcpella). Perfusion. 36, 2021, 535-7.
    pubmed
  • 5) Reed BN, et al. Survey of Anticoagulation Practices with the Impella Percutaneous Ventricular Assist Device at High-Volume Centers. J Interv Cardiol. 2019, 3791307.
    pubmed
  • 6) Akanni OJ, et al. EC-VAD:Combined Use of Extracorporeal Membrane Oxygenation and Percutaneous Microaxial Pump Left Ventricular Assist Device. ASAIO J. 65, 2019, 219-26.
    pubmed
  • 7) Pappalardo F, et al. Concomitant implantation of Impella(R) on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail. 19, 2017, 404-12.
  • 8) Patel SM, et al. Simultaneous Venoarterial Extracorporeal Membrane Oxygenation and Percutaneous Left Ventricular Decompression Therapy with Impella Is Associated with Improved Outcomes in Refractory Cardiogenic Shock. ASAIO J. 65, 2019, 21-8.
    pubmed
  • 9) 日本循環器学会ほか. 2023年改訂版心筋炎の診断・治療に関するガイドライン.
  • 10) Raffa GM, et al. Meta-Analysis of Peripheral or Central Extracorporeal Membrane Oxygenation in Postcardiotomy and Non-Postcardiotomy Shock. Ann Thorac Surg. 107, 2019, 311-21.
  • 11) 補助人工心臓治療関連学会協議会. 循環補助使用中の NYHA クラスと profile 分類のコンセンサス(2022.4.18確定). https://j-vad.jp/document/循環補助使用中の NYHA クラスと profile 分類のコンセンサス. pdf?ver=20220419A
  • 12) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会合同ガイドライン 2021年改訂版 重症心不全に対する植込型補助人工心臓治療ガイドライン.

P.214 掲載の参考文献

  • 1) 日本集中治療学会ほか. COVID-19急性呼吸不全への人工呼吸とECMO基本的注意事項. 第2版. 2020年3月24日. https://www.jsicm.org/news/upload/COVID-19-ECMOnet-info_20200324.pdf
  • 2) Mazzeffi, M, et al. Large Dual-Lumen Extracorporeal Membrane Oxygenation Cannulas Are Associated with More Intracranial Hemorrhage. ASAIO J. 2019, 65(7), 674-7.
    pubmed

P.222 掲載の参考文献

  • 1) 安野 誠ほか. PCPS の新たな結露対策について. 体外循環技術. 2010, 37(4), 436-9..
    Medical*Online
  • 2) 東條圭一ほか. 人工肺ガスフラッシュに関する検討. 体外循環技術. 2014, 41(1), 1-10.
    Medical*Online
  • 3) 東條圭一ほか. ECMO 施行時における人工肺ガス交換能不足に対する人工肺並列接続と直列接続の比較検討. 体外循環技術, 2022, 49(1), 1-6.
    Medical*Online
  • 4) 古垣達也ほか. 膜型人工肺稼働中の蒸泄による水喪失量の検討. 体外循環技術, 2018, 45(4), 380-2.
    Medical*Online
  • 5) 北里大学病院 ME部監修. 臨床工学技術ヴィジュアルシリーズ 動画と写真でまるわかり! 体外循環(初版). 学研メディカル秀潤社, 東京, 2022.
  • 6) 日本体外循環技術医学会学術委員会補助循環部会. 新型コロナウイルス感染症 (COVID-19)に対する ECMO 管理. 体外循環技術. 2020, 47(3), 230-8.
  • 7) 名徳倫明. 投与ルート内の薬物-薬物間相互作用と薬物-医療材料間相互作用. 薬局. 2015, 66(10), 2679-85.
    Medical*Online
  • 8) 日本体外循環技術医学会学術委員会補助循環部会. ECMO の記録やチェックリストに関する提案. 体外循環技術. 2022, 49(2), 144-52.

[ 第6章 ] 植込型補助人工心臓 ( 植込型VAD )

P.230 掲載の参考文献

  • 1) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会合同ガイドライン. 2021年改訂版重症心不全に対する植込型補助人工心臓治療ガイドライン. 2021. [https://www.j-circ.or.jp/cms/wpcontent/uploads/2021/03/JCS2021_Ono_Yamaguchi.pdf]
  • 2) 一般社団法人 補助人工心臓治療関連学会協議会. 植込型補助人工心臓 DT 実施基準 (2023.8.7改定).
  • 3) Louis E, et al. Initial experience with the Abiomed AB5000 ventricular assist device system. Ann Thorac Surg, 80(1), 2005, 309-12.
  • 4) Sato N, et al. Multi-institutional evaluation of the tokyo university ventricular assist system. ASAIO Trans. 36(3), 1990, M708-11.
    pubmed
  • 5) Takano H, et al. Multi-institutional studies of the national cardiovascular center ventricular assist system:Use in 92 patients. ASAIO Trans. 35(3), 1989, 541-4.
    pubmed
  • 6) Hetzer R, et al. Paediatric mechanical circulatory support with Berlin Heart EXCOR:development and outcome of a 23-year experience. Eur J Cardiothorac Surg. 50(2), 2016, 203-10.
    pubmed
  • 7) Frazier OH, et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac surg. 53(6), 1992, 1080-90.
    pubmed
  • 8) Daniel MA, et al. Clinical evaluation of the Novacor totally implantable ventricular assist system. Current status. ASAIO Trans. 37(3), 1991, M423-5.
    pubmed
  • 9) Rose EA, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 345(20), 2001, 1435-43.
    pubmed
  • 10) Wieselthaler GM, et al. First clinical experience with the Debakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation. 101(4), 2000, 356-9.
    pubmed
  • 11) Siegenthaler MP, et al. Advanced heart failure:Feasibility study of long-term continuous axial flow pump support. Eur Heart J. 26(10), 2005, 1031-8.
    pubmed
  • 12) Miller LW, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 357(9), 2007, 885-96.
    pubmed
  • 13) Morshuis M, et al. European experience of Duraheart magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac surg. 35(6), 2009, 1020-7, discussion 1027-8.
  • 14) Aaronson KD, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 125(25), 2012, 3191-200.
    pubmed
  • 15) Goldstein DJ, et al. Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. J Heart Lung. Transplant. 37(1), 2018, 7-14.
  • 16) Yamazaki K, et al. Completely pulsatile high flow circulatory support with a constant-speed centrifugal blood pump:Mechanisms and early clinical observations. General thorac Cardiovasc Surg. 55(4), 2007, 158-62.
  • 17) Worku B, et al. The CentriMag ventricular assist device in acute heart failure refractory to medical management. J Heart Lung Transplant.31(6), 2012, 611-7.
    pubmed
  • 18) Shimamura J, et al. Miniaturized centrifugal ventricular assist device for bridge to decision:Preclinical chronic study in a bovine model. Artificial Organs. 43(9), 2019, 821-7.
  • 19) 2023年日本循環器学会/日本心臓血管外科学会/日本心臓病学会/日本心血管インターベンション治療学会ガイドライン フォーカスアップデート版. PCPS/ECMO/循環補助用心内留置型 ポンプカテーテルの適応・操作. 2023. [https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Ono_Yamaguchi.pdf]
  • 20) 築谷朋典. 特集「わかりやすい人工心臓の要素技術」遠心型ポンプと軸流型ポンプ. 人工臓器. 43(1), 2014.61-5.
  • 21) Mascato F, et al. Engineering and clinical considerations in rotary blood pumps. Springer, Montalto A et al eds, Mechanical circulatory support in End-stage heart failure. 2017, 163-73.
  • 22) Hosseinipour M, et al. Rotary mechanical circulatory support systems. J Rehabil Assist Technol Eng. 4, 2017, 1-24.

P.241 掲載の参考文献

  • 1) Yamazaki K, et al. Completely pulsatile high flow circulatory support with a constant-speed centrifugal blood pump:mechanisms and early clinical observations. Gen Thorac Cardiovasc Surg. 55(4), 2007, 158-62.
    pubmed
  • 2) Tomoki Ushijima, et al. Potential of the EVAHEART 2 Double-Cuff Tipless Inflow Cannula for Prevention of Thromboembolic Events. ASAIO J. 68(10), 2022, e168-e171.
    pubmed
  • 3) Tuzun E, et al. The effect of intermittent low speed mode upon aortic valve opening in calves supported with a Jarvik 2000 axial flow device. ASAIO J. 51(2), 2005, 139-43.
    pubmed
  • 4) Westaby S, et al. Postauricular percutaneous power delivery for permanent mechanical circulatory support. J Thorac Cardiovasc Surg. 123(5), 2002, 977-83.
    pubmed
  • 5) Rogers JG, et al. Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure. N Engl J Med. 376(5), 2017, 451-60.
    pubmed
  • 6) Milano CA, et al. HVAD:The ENDURANCE Supplemental Trial. JACC Heart Fail. 6(9), 2018, 792-802.
    pubmed
  • 7) 絹川 弘一郎. Destination therapy 承認に至るプロセスと今後の課題. 人工臓器. 50(3), 2021, 236-40.
  • 8) Matthew J, et al. Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease:A multicenter registry analysis. J Heart Lung Transplant. 39(6), 2020, 573-9.
  • 9) Mehra MR, et al. A Fully Magnetically Levitated Left Ventricular Assist Device-Final Report. N Engl J Med. 380(17), 2019, 1618-27.
    pubmed

P.249 掲載の参考文献

  • 1) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会合同ガイドライン. 2021年改訂版重症心不全に対する植込型補助人工心臓治療ガイドライン. 2021. [https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Ono_Yamaguchi.pdf]
  • 2) 一般社団法人 補助人工心臓治療関連学会協議会. 植込型補助人工心臓 DT 実施基準(2021.3.19策定, 2022.4.18改定, 2023.8.7改定).
  • 3) 日本循環器学会ほか. 2016年版 心臓移植に関する提言. 2016. [https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2016_isobe_h.pdf]
  • 4) Stevenson LW, et al. INTERMACS profiles of advanced heart failure:the current picture. J Heart Lung Transplant. 28(6), 2009, 535-41.
    pubmed
  • 5) Nakatani T, et al. Japanese registry for mechanically assisted circulatory support:first report. J Heart Lung Transplant. 36(10), 2017, 1087-96.
    pubmed
  • 6) Kinugawa K, et al. The second official report from Japanese registry for mechanical assisted circulatory support (J-MACS):first results of bridge to bridge strategy. Gen Thorac Cardiovasc Surg, 68(2), 2020, 102-11.
    pubmed
  • 7) 日本循環器学会/日本心不全学会合同ガイドライン. 2021年 JCS/JHFS ガイドライン フォーカスアップデート版「急性・慢性心不全診療」. 2021. [https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Tsutsui.pdf]
  • 8) Kinugawa K, et al. Consensus report on destination therapy in Japan:From the DT Committee of the Council for Clinical Use of Ventricular Assist Device Related Academic Societies. Circ J. 85(10), 2021, 1906-17.
  • 9) Cowger J, et al. Predicting survival in patients receiving continuous flow left ventricular assist devices:the HeartMate II Risk Score. J Am Coll Cardiol, 61(3), 2013, 313-21.
    pubmed
  • 10) Stehlik J, et al. The HeartMate 3 Risk Score:Updating LVAD Risk Assessment for the Current Era. JACC Heart Fail, 10(12), 2022, 960-62.
    pubmed

P.254 掲載の参考文献

  • 1) 清野雄介. 最先端心臓血管外科手術の麻酔管理 左室補助人工心臓植込術の麻酔. 日臨麻会誌. 36(7), 2016, 687-95.
  • 2) Morita Y, et al. Modified Tricuspid Annular Plane Systolic Excursion Using Transesophageal Echocardiography and Its Utility to Predict Postoperative Course in Heart Transplantation and Left Ventricular Assist Device Implantation. J Cardiothorac Vasc Anesth. 32(3), 2018, 1316-24.
    pubmed
  • 3) Shinzato Y, et al. Clinical application of skin antisepsis using aqueous olanexidine:a scoping review. Acute Med Surg. 9(1), 2022, e723.
    pubmed
  • 4) Takeda K, et al. Device exchange from HeartMate II to HeartMate 3 left ventricular assist device. Interact Cardiovasc Thorac Surg. 29(3), 2019, 430-3.
    pubmed
  • 5) Chang HH, et al. Left ventricular assist device exchange from HeartMate II to HeartMate 3 in an Asian patient-a case report and literature review. J Cardiothorac Surg. 18(1), 2023, 82.
  • 6) Mutsuga M, et al. Impact of an improved driveline management for HeartMate II and HeartMate 3 left ventricular assist device. Artif Organs. 47(2), 2023, 387-95.
    pubmed
  • 7) Dean D, et al. SSI Registry Investigations. Reduction in driveline infection rates:Results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry. J Heart Lung Transplant. 34(6), 2015, 781-9.
    pubmed
  • 8) Park SJ, et al. Management of aortic insufficiency in patients with left ventricular assist devices:A simple coaptation sticth method (Park's stitch). J Thorac Cardiovasc Surg. 127(1), 2004, 264-6.
  • 9) Hanke JS, et al. In Vitro Evaluation of Inflow Cannula Fixation Techniques in Left Ventricular Assist Device Surgery. Artif Organs. 41(3), 2017, 272-5.
    pubmed
  • 10) Salerno C, et al. Heartmate 3 surgical implantation technique and outcomes in the MOMENTUM 3 Trial. J Heart lung Transplant. 25, 2006, 499-503.
  • 11) May-Newman K, et al. Reducing regional flow stasis and improving intraventricular hemodynamics with a tipless inflow cannula design:An in vitro flow visualization study using the EVAHEART LVAD. Atrif Organs. 43(9), 2019, 834-48.
  • 12) Motomura T, et al. Surgical Techniques for Implanting the EVAHEART 2 Double Cuff Tipless Inflow Cannula. ASAIO J. 65(8), 2019, e86-e89.
    pubmed
  • 13) Iizuka K, et al. Outflow graft anastomosis site design could be correlated to aortic valve regurgitation under left ventricular assist device support. J Atrif Organs. 21(2), 2018, 150-5.

P.261 掲載の参考文献

  • 1) 日本胸部外科学会. J-MACS Statistical Report 最新版. 2022年5月6日掲載. (https://www.jpats.org/society/jmacs/report.html)
  • 2) Sayer G, et al. On the Right Path:Predicting Right Ventricular Failure After Left Ventricular Assist Device. ASAIO J. 69(1), 2023, 82-5.
    pubmed
  • 3) Pahuja M, et al. Right Ventricular Afterload Sensitivity Has Been on My Mind. Circ Heart Fail. 12(9), 2019, e006345.
    pubmed
  • 4) 守尾嘉晃ほか. 肺高血圧症の展開 2014(Topics1)肺血管反応. 日本呼吸器学会誌. 3(4), 2014, 464-70.

P.268 掲載の参考文献

  • 1) 豊倉穣. 情報処理速度に関する簡便な認知検査の加齢変化-健常人における paced auditory serial addition task および trail making test の検討-. 脳と精神の医学. 7(4), 1996, 401-9.
  • 2) 柏公一ほか. 患者とその介護者に対して植込型補助人工心臓の機器取り扱いのトレーニングを効率的に行う方法に関する検討. 体外循環技術. 46(4), 2019, 377-81.
  • 3) 一般社団法人 補助人工心臓治療関連学会協議会. 植込型補助人工心臓 DT 実施基準(2022.4.18改訂). [https://j-vad.jp/dt-lvad#oshirase20220815 (2023.6.19閲覧)]
  • 4) 柏公一ほか. 植込型補助人工心臓の機器取り扱い上のミスを引き起こす要因に関する検討-植込型補助人工心臓装着患者が引き起こすミスを減らすためには?-. 体外循環技術. 2018, 45(4), 375-9.
    Medical*Online
  • 5) 柏公一. 植込み型補助人工心臓の教育と管理の標準化の必要性について-シームレスな植込み型補助人工心臓の管理を目指して-. 人工臓器. 51(3), 2022, 188-92.
はじめての方へ
個人／法人会員登録のご案内